Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2026-02-17 @ 7:23 PM
Study NCT ID:
NCT06344169
Status:
RECRUITING
Last Update Posted:
2025-05-09
First Post:
2024-03-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section
Sponsor:
Dalin Tzu Chi General Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
DTCRD112(2)-I-15
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None